PART I . Overview Invivyd, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. We are devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2, the virus that causes COVID-19. PEMGARDA (pemivibart) is our first mAb to receive regulatory authorization and was designed to exert continuous pharmaceutical a...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001193125-26-092547 | EDGAR | 127K words |
| 2025-03-20 | 2024-12-31 | 0000950170-25-042332 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0000950170-24-037610 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009516 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000950170-22-005112 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-268076 | EDGAR | 35K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-109029 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-071974 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-126735 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-096674 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057017 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062043 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041352 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021235 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024516 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017242 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0000950170-22-009799 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-05 | 0001193125-26-092528 | EDGAR | 5K words |
| 2026-01-08 | 0001193125-26-006997 | EDGAR | — |
| 2025-12-23 | 0001193125-25-329488 | EDGAR | — |
| 2025-11-24 | 0001193125-25-291992 | EDGAR | — |
| 2025-11-19 | 0001193125-25-288347 | EDGAR | — |
| 2025-11-06 | 0001193125-25-268057 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258526 | EDGAR | — |
| 2025-10-06 | 0001193125-25-230898 | EDGAR | — |
| 2025-09-24 | 0001193125-25-215541 | EDGAR | — |
| 2025-08-22 | 0000950170-25-110952 | EDGAR | — |
129 total filings indexed. 102 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001832038 |
| Ticker | IVVD |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.invivyd.com |
| Listed | 2021-08-06 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report